Impact of age and comorbidity on survival in colorectal cancer

Patients with colorectal cancer are often excluded from clinical trials based on age or a poor performance score. However, 70% of colorectal cancer is diagnosed in patients over 65. Evaluation on the influence of age and comorbidity on survival and cause of death in a non-selected population. Includ...

Full description

Saved in:
Bibliographic Details
Published in:Journal of gastrointestinal oncology 2015-12, Vol.6 (6), p.605-612
Main Authors: van Eeghen, Elmer E, Bakker, Sandra D, van Bochove, Aart, Loffeld, Ruud J L F
Format: Article
Language:English
Subjects:
Original
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c322t-1b51b5309d25ee0436726824f48bd0528160622e9f09ef79de4817627d7b501c3
cites
container_end_page 612
container_issue 6
container_start_page 605
container_title Journal of gastrointestinal oncology
container_volume 6
creator van Eeghen, Elmer E
Bakker, Sandra D
van Bochove, Aart
Loffeld, Ruud J L F
description Patients with colorectal cancer are often excluded from clinical trials based on age or a poor performance score. However, 70% of colorectal cancer is diagnosed in patients over 65. Evaluation on the influence of age and comorbidity on survival and cause of death in a non-selected population. Included were 621 consecutive patients with colorectal cancer. An extensive chart review was performed for 392 patients with colon cancer and 143 patients with rectal cancer. Analyses were performed separately for both groups. Median survival of colon cancer patients was 5.13 years, 131 patients (34.3%) died from tumour progression. Age and comorbidity were significant predictors for overall survival (P
doi_str_mv 10.3978/j.issn.2078-6891.2015.070
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4671847</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1751671574</sourcerecordid><originalsourceid>FETCH-LOGICAL-c322t-1b51b5309d25ee0436726824f48bd0528160622e9f09ef79de4817627d7b501c3</originalsourceid><addsrcrecordid>eNpVUF1LwzAUDaK4MfcXpL750pqk-XwZyHA6GPii4FtJ03RmtMlM2sH-vQE30cuFey7ncM7lAnCHYFFKLh52hY3RFRhykTMhUUKIFpDDCzDFGMmccflxmfBZMAHzGHcwFZEUUnwNJpgxyZFEU7BY93ulh8y3mdqaTLkm0773obaNHY6Zd1kcw8EeVJdZl6jOB6OHtGnltAk34KpVXTTz05yB99XT2_Il37w-r5ePm1yXGA85qmnqEsoGU2MgKRnHTGDSElE36SSBGGQYG9lCaVouG0ME4gzzhtcUIl3OwOLHdz_WvWm0cUNQXbUPtlfhWHllq_-Ms5_V1h8qwjgShCeD-5NB8F-jiUPV26hN1yln_BgrxClKUspJkt7-zfoNOT-t_AYDR3GB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1751671574</pqid></control><display><type>article</type><title>Impact of age and comorbidity on survival in colorectal cancer</title><source>PubMed Central</source><creator>van Eeghen, Elmer E ; Bakker, Sandra D ; van Bochove, Aart ; Loffeld, Ruud J L F</creator><creatorcontrib>van Eeghen, Elmer E ; Bakker, Sandra D ; van Bochove, Aart ; Loffeld, Ruud J L F</creatorcontrib><description>Patients with colorectal cancer are often excluded from clinical trials based on age or a poor performance score. However, 70% of colorectal cancer is diagnosed in patients over 65. Evaluation on the influence of age and comorbidity on survival and cause of death in a non-selected population. Included were 621 consecutive patients with colorectal cancer. An extensive chart review was performed for 392 patients with colon cancer and 143 patients with rectal cancer. Analyses were performed separately for both groups. Median survival of colon cancer patients was 5.13 years, 131 patients (34.3%) died from tumour progression. Age and comorbidity were significant predictors for overall survival (P&lt;0.001). Age was also a significant predictor of cause of death (P=0.001). In rectal cancer patients median survival was 4.67 years, 51 (35.7%) of patients died from tumour progression. Neither age nor comorbidity was significant predictors of survival. Age was a significant predictor of cause of death (P&lt;0.001). In colon cancer patient age and comorbidity predict survival. This represents possible bias or a reduced survival benefit of treatment, and is an indication that colon cancer is not the prognosis defining illness in the majority of patients. In rectal cancer patients neither age or comorbidity significantly impacted survival.</description><identifier>ISSN: 2078-6891</identifier><identifier>EISSN: 2219-679X</identifier><identifier>DOI: 10.3978/j.issn.2078-6891.2015.070</identifier><identifier>PMID: 26697191</identifier><language>eng</language><publisher>China: AME Publishing Company</publisher><subject>Original</subject><ispartof>Journal of gastrointestinal oncology, 2015-12, Vol.6 (6), p.605-612</ispartof><rights>2015 Journal of Gastrointestinal Oncology. All rights reserved. 2015 Journal of Gastrointestinal Oncology.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c322t-1b51b5309d25ee0436726824f48bd0528160622e9f09ef79de4817627d7b501c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671847/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671847/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26697191$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Eeghen, Elmer E</creatorcontrib><creatorcontrib>Bakker, Sandra D</creatorcontrib><creatorcontrib>van Bochove, Aart</creatorcontrib><creatorcontrib>Loffeld, Ruud J L F</creatorcontrib><title>Impact of age and comorbidity on survival in colorectal cancer</title><title>Journal of gastrointestinal oncology</title><addtitle>J Gastrointest Oncol</addtitle><description>Patients with colorectal cancer are often excluded from clinical trials based on age or a poor performance score. However, 70% of colorectal cancer is diagnosed in patients over 65. Evaluation on the influence of age and comorbidity on survival and cause of death in a non-selected population. Included were 621 consecutive patients with colorectal cancer. An extensive chart review was performed for 392 patients with colon cancer and 143 patients with rectal cancer. Analyses were performed separately for both groups. Median survival of colon cancer patients was 5.13 years, 131 patients (34.3%) died from tumour progression. Age and comorbidity were significant predictors for overall survival (P&lt;0.001). Age was also a significant predictor of cause of death (P=0.001). In rectal cancer patients median survival was 4.67 years, 51 (35.7%) of patients died from tumour progression. Neither age nor comorbidity was significant predictors of survival. Age was a significant predictor of cause of death (P&lt;0.001). In colon cancer patient age and comorbidity predict survival. This represents possible bias or a reduced survival benefit of treatment, and is an indication that colon cancer is not the prognosis defining illness in the majority of patients. In rectal cancer patients neither age or comorbidity significantly impacted survival.</description><subject>Original</subject><issn>2078-6891</issn><issn>2219-679X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVUF1LwzAUDaK4MfcXpL750pqk-XwZyHA6GPii4FtJ03RmtMlM2sH-vQE30cuFey7ncM7lAnCHYFFKLh52hY3RFRhykTMhUUKIFpDDCzDFGMmccflxmfBZMAHzGHcwFZEUUnwNJpgxyZFEU7BY93ulh8y3mdqaTLkm0773obaNHY6Zd1kcw8EeVJdZl6jOB6OHtGnltAk34KpVXTTz05yB99XT2_Il37w-r5ePm1yXGA85qmnqEsoGU2MgKRnHTGDSElE36SSBGGQYG9lCaVouG0ME4gzzhtcUIl3OwOLHdz_WvWm0cUNQXbUPtlfhWHllq_-Ms5_V1h8qwjgShCeD-5NB8F-jiUPV26hN1yln_BgrxClKUspJkt7-zfoNOT-t_AYDR3GB</recordid><startdate>20151201</startdate><enddate>20151201</enddate><creator>van Eeghen, Elmer E</creator><creator>Bakker, Sandra D</creator><creator>van Bochove, Aart</creator><creator>Loffeld, Ruud J L F</creator><general>AME Publishing Company</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20151201</creationdate><title>Impact of age and comorbidity on survival in colorectal cancer</title><author>van Eeghen, Elmer E ; Bakker, Sandra D ; van Bochove, Aart ; Loffeld, Ruud J L F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c322t-1b51b5309d25ee0436726824f48bd0528160622e9f09ef79de4817627d7b501c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Original</topic><toplevel>online_resources</toplevel><creatorcontrib>van Eeghen, Elmer E</creatorcontrib><creatorcontrib>Bakker, Sandra D</creatorcontrib><creatorcontrib>van Bochove, Aart</creatorcontrib><creatorcontrib>Loffeld, Ruud J L F</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of gastrointestinal oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Eeghen, Elmer E</au><au>Bakker, Sandra D</au><au>van Bochove, Aart</au><au>Loffeld, Ruud J L F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of age and comorbidity on survival in colorectal cancer</atitle><jtitle>Journal of gastrointestinal oncology</jtitle><addtitle>J Gastrointest Oncol</addtitle><date>2015-12-01</date><risdate>2015</risdate><volume>6</volume><issue>6</issue><spage>605</spage><epage>612</epage><pages>605-612</pages><issn>2078-6891</issn><eissn>2219-679X</eissn><abstract>Patients with colorectal cancer are often excluded from clinical trials based on age or a poor performance score. However, 70% of colorectal cancer is diagnosed in patients over 65. Evaluation on the influence of age and comorbidity on survival and cause of death in a non-selected population. Included were 621 consecutive patients with colorectal cancer. An extensive chart review was performed for 392 patients with colon cancer and 143 patients with rectal cancer. Analyses were performed separately for both groups. Median survival of colon cancer patients was 5.13 years, 131 patients (34.3%) died from tumour progression. Age and comorbidity were significant predictors for overall survival (P&lt;0.001). Age was also a significant predictor of cause of death (P=0.001). In rectal cancer patients median survival was 4.67 years, 51 (35.7%) of patients died from tumour progression. Neither age nor comorbidity was significant predictors of survival. Age was a significant predictor of cause of death (P&lt;0.001). In colon cancer patient age and comorbidity predict survival. This represents possible bias or a reduced survival benefit of treatment, and is an indication that colon cancer is not the prognosis defining illness in the majority of patients. In rectal cancer patients neither age or comorbidity significantly impacted survival.</abstract><cop>China</cop><pub>AME Publishing Company</pub><pmid>26697191</pmid><doi>10.3978/j.issn.2078-6891.2015.070</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2078-6891
ispartof Journal of gastrointestinal oncology, 2015-12, Vol.6 (6), p.605-612
issn 2078-6891
2219-679X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4671847
source PubMed Central
subjects Original
title Impact of age and comorbidity on survival in colorectal cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T05%3A18%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20age%20and%20comorbidity%20on%20survival%20in%20colorectal%20cancer&rft.jtitle=Journal%20of%20gastrointestinal%20oncology&rft.au=van%20Eeghen,%20Elmer%20E&rft.date=2015-12-01&rft.volume=6&rft.issue=6&rft.spage=605&rft.epage=612&rft.pages=605-612&rft.issn=2078-6891&rft.eissn=2219-679X&rft_id=info:doi/10.3978/j.issn.2078-6891.2015.070&rft_dat=%3Cproquest_pubme%3E1751671574%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c322t-1b51b5309d25ee0436726824f48bd0528160622e9f09ef79de4817627d7b501c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1751671574&rft_id=info:pmid/26697191&rfr_iscdi=true